Ftse Mib
34.272,10
-0,30%
DAX
18.514,87
-0,46%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
63.545,79
-2,01%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Mds (MDZ) Mds (MDZ) Notizie

MDZ

Mds (MDZ)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:MDZ
DataOraFonteTitoloSimboloCompagnia
01/02/200714:00PR Newswire (US)MDS to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device ConferenceNYSE:MDZ
29/01/200714:00PR Newswire (US)MDS Offers to Acquire Molecular Devices for US$615 Million in Major Expansion of MDS Sciex BusinessNYSE:MDZ
17/01/200714:00PR Newswire (US)First Patients in India Receive Innovative Treatment for Primary Liver CancerNYSE:MDZMds
11/01/200703:10PR Newswire (US)FDA Clarifies Path to Review Completion for MDS Bioanalytical ClientsNYSE:MDZMds
10/01/200714:00PR Newswire (US)Expanded use for TheraSphere(R) offers physicians an innovative alternative to traditional liver cancer therapiesNYSE:MDZMds
08/01/200714:00PR Newswire (US)MDS Announces Changes to the Company's Board of DirectorsNYSE:MDZMds
03/01/200714:00PR Newswire (US)MDS To Present At JPMorgan Healthcare ConferenceNYSE:MDZ
14/12/200613:00PR Newswire (US)/FIRST AND FINAL ADD - TO490 - MDS Inc./NYSE:MDZ
14/12/200613:00PR Newswire (US)MDS Reports Fourth Quarter and Fiscal 2006 ResultsNYSE:MDZ
12/12/200614:00PR Newswire (US)MDS Announces Quarterly DividendNYSE:MDZ
07/12/200614:00PR Newswire (US)MDS to Release Fourth Quarter and Year End ResultsNYSE:MDZ
10/11/200613:00PR Newswire (US)MDS Announces Senior Management ChangeNYSE:MDZ
30/10/200614:00PR Newswire (US)MDS To Present At CIBC World Markets Healthcare ConferenceNYSE:MDZ
24/10/200615:00PR Newswire (US)MDS Sciex Signs Agreement with SCRUM Inc. to Distribute Innovative Drug Screening Technology for the First Time in JapanNYSE:MDZMds
17/10/200615:00PR Newswire (US)MDS Pharma Services opens its first U.S. central labNYSE:MDZ
27/09/200615:00PR Newswire (US)MDS to Present at CIBC World Markets Institutional Investor ConferenceNYSE:MDZ
26/09/200615:00PR Newswire (US)First Clinical Trial Launched by MDS Nordion to Study Innovative Cancer TreatmentNYSE:MDZMds
18/09/200615:00PR Newswire (US)MDS to Present at the UBS Global Life Sciences ConferenceNYSE:MDZ
01/09/200615:00PR Newswire (US)MDS Pharma Services Hires Industry Experts to Support Biopharmaceutical Development and MDS Growth StrategyNYSE:MDZ
01/09/200600:00PR Newswire (US)Waters Corporation to Integrate Ultra Performance Liquid Chromatography into Applied Biosystems/MDS SCIEX Mass Spectrometry SofNYSE:MDZMds
19/07/200615:00PR Newswire (US)MDS Pharma Services Launches Metabolic Disorders InitiativeNYSE:MDZ
23/06/200615:20PR Newswire (US)Iconix Study Drives Methods for Discovering and Validating Predictive Toxicology BiomarkersNYSE:MDZMds
15/06/200615:00PR Newswire (US)MDS Pharma Services Named Top CRO in EuropeNYSE:MDZ
08/06/200614:00PR Newswire (US)/FIRST AND FINAL ADD - TO158 - MDS Inc./NYSE:MDZ
08/06/200614:00PR Newswire (US)MDS Reports Second Quarter 2006 Financial ResultsNYSE:MDZ
06/06/200615:00PR Newswire (US)MDS to Present at Goldman Sachs Global Healthcare ConferenceNYSE:MDZ
10/05/200615:00PR Newswire (US)MDS to Present at Bank of America Healthcare ConferenceNYSE:MDZ
27/04/200614:00PR Newswire (US)David Spaight Joins MDS as President of Pharma ServicesNYSE:MDZ
25/04/200615:00PR Newswire (US)MDS to Present at the Scotia Capital Pharmaceutical & Biotechnology ConferenceNYSE:MDZ
19/04/200615:00PR Newswire (US)MDS Nordion Signs Agreement with Bradmer Pharmaceuticals Inc. for Novel Brain Cancer TherapeuticNYSE:MDZ
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:MDZ

La tua Cronologia

LSE
0RMO
Nomad Foods
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network